Aberdeen Group’s Geron GERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,527,083
Closed -$12.6M 955
2025
Q4
$12.6M Buy
9,527,083
+3,556,160
+60% +$4.46M 0.02% 567
2025
Q3
$8.18M Sell
5,970,923
-1,015,009
-15% -$1.35M 0.01% 640
2025
Q2
$9.85M Buy
6,985,932
+3,293,179
+89% +$4.67M 0.02% 598
2025
Q1
$5.87M Buy
3,692,753
+1,845,468
+100% +$4.49M 0.01% 664
2024
Q4
$6.54M Buy
1,847,285
+360,027
+24% +$1.44M 0.01% 599
2024
Q3
$6.75M Buy
+1,487,258
New +$6.76M 0.01% 601

Other funds holding GERN

Aberdeen Group's GERN Position: Q1 2026 in Review

Aberdeen Group sold out of Geron (GERN) in Q1 2026, closing a stake of 9,527,083 shares — an estimated $12.6M sold.

Aberdeen Group first reported a position in GERN in Q3 2024 and held it in 6 quarters. The position peaked at $12.6M in Q4 2025. 256 funds tracked by Wall St. Rank hold GERN as of Q1 2026.

  • Aberdeen Group reported no remaining Geron position as of Q1 2026 after selling out during the quarter.
  • Aberdeen Group sold 9,527,083 Geron shares in Q1 2026, an estimated $12.6M.
  • Aberdeen Group first reported a position in Geron in Q3 2024 and held it in 6 quarters.
  • Aberdeen Group's Geron position peaked at $12.6M in Q4 2025.
  • 256 funds tracked by Wall St. Rank held Geron as of Q1 2026.

Based on Aberdeen Group's 13F filing for Q1 2026, filed 29 Apr 2026.